Multitarget In Silico evaluation of HPLC-Identified phytoconstituents from Phyllanthus amarus against diabetes-related enzymes
Abstract
Diabetes mellitus is characterised by persistent hyperglycaemia and progressive metabolic complications. Because several enzymes contribute to postprandial glucose elevation and the polyol pathway, compounds capable of acting on multiple targets may serve as useful leads for diabetes management. This study investigated compounds identified in an aqueous extract of Phyllanthus amarus using an integrated high-performance liquid chromatography- diode array detector (HPLC-DAD), molecular docking, and Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) approach. The extract was profiled by HPLC-DAD, and the identified compounds were docked against α-amylase, α-glucosidase, aldose reductase, and sorbitol dehydrogenase. Predicted pharmacokinetic and toxicity properties were assessed using ADMETlab 2.0. Eleven compounds were detected, with flavonoids representing an important proportion of the profile. Hesperidin produced the most favorable docking scores against α-glucosidase (−8.8 kcal/mol) and sorbitol dehydrogenase (−8.7 kcal/mol). Myricetin showed the best docking score against aldose reductase (−8.8 kcal/mol), whereas naringenin exhibited the strongest interaction with α-amylase (−7.6 kcal/mol). These scores were more favorable than those obtained for the corresponding reference inhibitors in the docking analysis. Myricetin and naringenin satisfied Lipinski's Rule of Five, whereas hesperidin showed violations that were likely related to its glycosylated structure. The findings identify several P. amarus constituents as potential multitarget antidiabetic leads that warrant further experimental validation.